Drug Pipeline

MM120 (LSD D-Tartrate) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
4
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT07592689
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Trial sites expanded: 18 -> 27 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-18 NCT07592689 A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) Phase 3 Recruiting
Active Studies by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07592689 A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) Major Depressive Disorder Recruiting
NCT06941844 A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge) Major Depressive Disorder Active, Not Recruiting
NCT06741228 A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) Generalized Anxiety Disorder Active, Not Recruiting
NCT06809595 A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) Generalized Anxiety Disorder Active, Not Recruiting
Sponsors Running MM120 (LSD D-Tartrate) Trials
Disease Areas
Get alerts when MM120 (LSD D-Tartrate) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free